Pharmacogenomics and Updates in Diabetes Management

Course overview

1. Describe the current framework, recommendations, and evidence to apply patient specific pharmacogenomic information to individualized treatment decisions. 2. Evaluate various drug interactions and patient specific pharmacogenomic drug interaction considerations. 3. Discuss guideline updates in the management of diabetes mellitus, including cardiovascular and renal considerations and their impact on pharmacotherapy selection . 4. Identify how continuous glucose monitors can be utilized to optimize pharmacotherapy regimens for patients with diabetes. 5. Apply the updates discussed for vaccinations, hormonal and osteoporosis therapies, and diabetes management through a series of interactive patient cases and discussions .